4.58
+0.37(+8.79%)
Currency In USD
| Previous Close | 4.21 |
| Open | 4.34 |
| Day High | 4.64 |
| Day Low | 4.34 |
| 52-Week High | 29.4 |
| 52-Week Low | 3 |
| Volume | 106,268 |
| Average Volume | 125,466 |
| Market Cap | 30.7M |
| PE | -0.4 |
| EPS | -11.59 |
| Moving Average 50 Days | 3.96 |
| Moving Average 200 Days | 8.32 |
| Change | 0.37 |
If you invested $1000 in Generation Bio Co. (GBIO) since IPO date, it would be worth $18.55 as of August 05, 2025 at a share price of $4.58. Whereas If you bought $1000 worth of Generation Bio Co. (GBIO) shares 3 years ago, it would be worth $56.68 as of August 05, 2025 at a share price of $4.58.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Generation Bio Announces 1-for-10 Reverse Stock Split
GlobeNewswire Inc.
Jul 18, 2025 12:35 PM GMT
CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that it will implement a 1-fo
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Jul 07, 2025 8:05 PM GMT
CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that, on July 1, 2025, the com
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire Inc.
May 28, 2025 10:59 AM GMT
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president